So far, we reported that CLDN2, which is highly expressed in human lung adenocarcinoma tissues and cell lines, induces chemoresistance against anticancer drugs including DXR, cisplatin, and docetaxel in A549 spheroid cells [19]. The gene discussed is CLDN2; the disease is lung adenocarcinoma.